Header Logo

Connection

George Abraham to Humans

Back to Details
This is a "connection" page, showing publications George Abraham has written about Humans.
George Abraham
Connection Strength
0.578
Humans
  1. Mishra AK, Abraham BM, Sahu KK, George AA, Sargent J, Kranis MJ, George SV, Abraham GM. Harms and Contributors of Leaving Against Medical Advice in Patients With Infective Endocarditis. J Patient Saf. 2022 12 01; 18(8):756-759.
    View in: PubMed
    Score: 0.029
  2. Mishra A, Sahu KK, Abraham BM, Sargent J, Kranis MJ, George SV, Abraham G. Predictors, patterns and outcomes following Infective endocarditis and stroke. Acta Biomed. 2022 05 11; 93(2):e2022203.
    View in: PubMed
    Score: 0.029
  3. Cho RJ, Senitko M, Wong J, Dincer EH, Khosravi H, Abraham GE. Feasibility of Using the O-Arm Imaging System During ENB-rEBUS-guided Peripheral Lung Biopsy: A Dual-center Experience. J Bronchology Interv Pulmonol. 2021 Oct 01; 28(4):248-254.
    View in: PubMed
    Score: 0.028
  4. Abraham GM, Saravolatz LD. The American Board of Internal Medicine's New Longitudinal Assessment Option and What It Means for Infectious Disease Specialists. Clin Infect Dis. 2021 05 18; 72(10):1854-1857.
    View in: PubMed
    Score: 0.027
  5. Mishra A, George AA, Sahu KK, Lal A, Abraham G. Tuberculosis and COVID-19 Co-infection: An Updated Review. Acta Biomed. 2020 11 10; 92(1):e2021025.
    View in: PubMed
    Score: 0.026
  6. Abraham GM, Morton JB, Saravolatz LD. Baloxavir: A Novel Antiviral Agent in the Treatment of Influenza. Clin Infect Dis. 2020 10 23; 71(7):1790-1794.
    View in: PubMed
    Score: 0.026
  7. Abraham GM, Obley AJ, Humphrey LL, Qaseem A, Centor RM, Akl E, Forceia MA, Haeme R, Hamilton PG, Hood GA, Jokela JA, Kansagara DL, Levine MA, Mason JR, Marcucci M. World Health Organization Guidelines on Treatment of Hepatitis C Virus Infection: Best Practice Advice From the American College of Physicians. Ann Intern Med. 2021 01; 174(1):98-100.
    View in: PubMed
    Score: 0.026
  8. Sullivan KM, Nicolas SE, Burton SJ, Spooner LM, Kanaan AO, Abraham GM. Innovative approach for sustaining an institutional medication safety committee. Am J Health Syst Pharm. 2020 05 19; 77(11):826-829.
    View in: PubMed
    Score: 0.025
  9. Lal A, Abraham GM. Utility of CD4 Cell Count and Viral Load Assay in Hospitalized Patients with Known HIV Infection: High Value Care Exercise. Infect Disord Drug Targets. 2020; 20(4):486-490.
    View in: PubMed
    Score: 0.025
  10. Lal A, Mishra AK, Sahu KK, Abraham GM. Machine Learning and Patient Expectations: Potential Point of Disconnect. Am J Med. 2019 10; 132(10):e750.
    View in: PubMed
    Score: 0.024
  11. Lal A, Mishra AK, Sahu KK, Abraham GM. The return of Koch's: Ineffective treatment or re-infection. Enferm Infecc Microbiol Clin (Engl Ed). 2020 Mar; 38(3):144-145.
    View in: PubMed
    Score: 0.024
  12. Abraham GM, Spooner LM. Citius, Altius, Fortius: The New Paradigm in the Treatment of Chronic Hepatitis C Disease. Clin Infect Dis. 2018 01 18; 66(3):464-474.
    View in: PubMed
    Score: 0.021
  13. Spooner LM, Abraham GM. Sustained virological response in a treatment-experienced patient with hepatitis C virus genotype 6 infection: Follow-up on a reported case. Am J Health Syst Pharm. 2017 04 15; 74(8):555.
    View in: PubMed
    Score: 0.020
  14. Spooner LM, Abraham GM. Retreatment of a treatment-experienced patient with genotype 6 hepatitis C virus infection: follow-up on a reported case. Am J Health Syst Pharm. 2015 Jan 01; 72(1):14-6.
    View in: PubMed
    Score: 0.017
  15. Abraham GM, Spooner LM. Sofosbuvir in the treatment of chronic hepatitis C: new dog, new tricks. Clin Infect Dis. 2014 Aug 01; 59(3):411-5.
    View in: PubMed
    Score: 0.017
  16. Gammal RS, Spooner LM, Abraham GM. Failed triple therapy in a treatment-experienced patient with genotype 6 hepatitis C infection. Am J Health Syst Pharm. 2014 Feb 01; 71(3):204-8.
    View in: PubMed
    Score: 0.016
  17. Chhabra L, Abraham GM. An unusual oro-naso-sinus communication resulting from heroin and cocaine snorting. BMJ Case Rep. 2013 Jul 02; 2013.
    View in: PubMed
    Score: 0.016
  18. Seed SM, Spooner LM, O'Connor K, Abraham GM. A multidisciplinary approach in travel medicine: the pharmacist perspective. J Travel Med. 2011 Sep-Oct; 18(5):352-4.
    View in: PubMed
    Score: 0.014
  19. Shanmugavel Geetha H, Teo YX, Ravichandran S, Perkit NR, Gogtay M, Lal A, Abraham GM, Trivedi N. Use of Sodium-glucose cotransporter 2 (SGLT 2) inhibitor is associated with reduced emergency room visits and hospitalizations in patients with Chronic obstructive pulmonary disease (COPD) and type 2 Diabetes Mellitus. Respir Med. 2024 Nov-Dec; 234:107819.
    View in: PubMed
    Score: 0.009
  20. Qaseem A, Yost J, Abraham GM, Andrews RA, Jokela JA, Miller MC, Humphrey LL, Obley AJ, Dunn AS, Haeme R, Lee RA, Saini SD, Tschanz MP, Etxeandia-Ikobaltzeta I, Harrod CS, Shamliyan T. Outpatient Treatment of Confirmed COVID-19: Living, Rapid Practice Points From the American College of Physicians (Version 2, Update Alert). Ann Intern Med. 2024 Aug; 177(8):e2400128.
    View in: PubMed
    Score: 0.008
  21. Ziegler CGK, Owings AH, Galeas-Pena M, Kazer SW, Miao VN, Navia AW, Tang Y, Bromley JD, Lotfy P, Sloan M, Laird H, Williams HB, George M, Drake RS, Pride Y, Abraham GE, Senitko M, Robinson TO, Diamond G, Lionakis MS, Shalek AK, Ordovas-Montanes J, Horwitz BH, Glover SC. An enhanced IL17 and muted type I interferon nasal epithelial cell state characterizes severe COVID-19 with fungal coinfection. Microbiol Spectr. 2024 Jun 04; 12(6):e0351623.
    View in: PubMed
    Score: 0.008
  22. Qaseem A, Yost J, Abraham GM, Andrews R, Jokela JA, Miller MC, Humphrey LL, Dunn A, Haeme R, Lee R, Saini SD, Tschanz CMP, Etxeandia-Ikobaltzeta I, Harrod C, Shamliyan T, Umana K. Outpatient Treatment of Confirmed COVID-19: Living, Rapid Practice Points From the American College of Physicians (Version 2). Ann Intern Med. 2023 10; 176(10):1396-1404.
    View in: PubMed
    Score: 0.008
  23. Ganatra S, Dani SS, Ahmad J, Kumar A, Shah J, Abraham GM, McQuillen DP, Wachter RM, Sax PE. Oral Nirmatrelvir and Ritonavir in Nonhospitalized Vaccinated Patients With Coronavirus Disease 2019. Clin Infect Dis. 2023 02 18; 76(4):563-572.
    View in: PubMed
    Score: 0.008
  24. Qaseem A, Yost J, Miller MC, Andrews R, Jokela JA, Forciea MA, Abraham GM, Humphrey LL, Lee RA, Tschanz MP, Etxeandia-Ikobaltzeta I, Harrod C, Shamliyan T, Umana K. Outpatient Treatment of Confirmed COVID-19: Living, Rapid Practice Points From the American College of Physicians (Version 1). Ann Intern Med. 2023 01; 176(1):115-124.
    View in: PubMed
    Score: 0.008
  25. Abraham S, Nohria A, Neilan TG, Asnani A, Saji AM, Shah J, Lech T, Grossman J, Abraham GM, McQuillen DP, Martin DT, Sax PE, Dani SS, Ganatra S. Cardiovascular Drug Interactions With?Nirmatrelvir/Ritonavir in Patients?With COVID-19: JACC?Review Topic of the Week. J Am Coll Cardiol. 2022 11 15; 80(20):1912-1924.
    View in: PubMed
    Score: 0.007
  26. Qaseem A, Yost J, Etxeandia-Ikobaltzeta I, Abraham GM, Jokela JA, Forciea MA, Miller MC, Humphrey LL. Should Remdesivir Be Used for the Treatment of Patients With COVID-19? Rapid, Living Practice Points From the American College of Physicians (Version 2, Update Alert 3). Ann Intern Med. 2022 05; 175(5):W55-W57.
    View in: PubMed
    Score: 0.007
  27. Qaseem A, Yost J, Etxeandia-Ikobaltzeta I, Forciea MA, Abraham GM, Miller MC, Obley AJ, Humphrey LL, Akl EA, Andrews R, Dunn A, Haeme R, Kansagara DL, Tschanz MP. What Is the Antibody Response and Role in Conferring Natural Immunity After SARS-CoV-2 Infection? Rapid, Living Practice Points From the American College of Physicians (Version 2). Ann Intern Med. 2022 04; 175(4):556-565.
    View in: PubMed
    Score: 0.007
  28. Qaseem A, Yost J, Etxeandia-Ikobaltzeta I, Abraham GM, Jokela JA, Miller MC, Forciea MA, Humphrey LL. Update Alert 2: Should Remdesivir Be Used for the Treatment of Patients With COVID-19? Rapid, Living Practice Points From the American College of Physicians (Version 2). Ann Intern Med. 2021 12; 174(12):W116-W117.
    View in: PubMed
    Score: 0.007
  29. Liu JJ, Sloan ME, Owings AH, Figgins E, Gauthier J, Gharaibeh R, Robinson T, Williams H, Sindel CB, Backus F, Ayyalasomayajula K, Parker A, Senitko M, Abraham GE, Claggett B, Horwitz BH, Jobin C, Adelman RM, Diamond G, Glover SC. Increased ACE2 Levels and Mortality Risk of Patients With COVID-19 on Proton Pump Inhibitor Therapy. Am J Gastroenterol. 2021 08 01; 116(8):1638-1645.
    View in: PubMed
    Score: 0.007
  30. Ziegler CGK, Miao VN, Owings AH, Navia AW, Tang Y, Bromley JD, Lotfy P, Sloan M, Laird H, Williams HB, George M, Drake RS, Christian T, Parker A, Sindel CB, Burger MW, Pride Y, Hasan M, Abraham GE, Senitko M, Robinson TO, Shalek AK, Glover SC, Horwitz BH, Ordovas-Montanes J. Impaired local intrinsic immunity to SARS-CoV-2 infection in severe COVID-19. Cell. 2021 09 02; 184(18):4713-4733.e22.
    View in: PubMed
    Score: 0.007
  31. Qaseem A, Yost J, Etxeandia-Ikobaltzeta I, Abraham GM, Jokela JA, Miller MC, Forciea MA, Humphrey LL, Dunn A, Andrews R, Haeme R, Tschanz MP. Update Alert: Should Remdesivir Be Used for the Treatment of Patients With COVID-19? Rapid, Living Practice Points From the American College of Physicians (Version 2). Ann Intern Med. 2021 09; 174(9):W66-W67.
    View in: PubMed
    Score: 0.007
  32. Qaseem A, Yost J, Etxeandia-Ikobaltzeta I, Forciea MA, Abraham GM, Miller MC, Obley AJ, Humphrey LL, Centor RM, Akl EA, Andrews R, Bledsoe TA, Haeme R, Kansagara DL. What Is the Antibody Response and Role in Conferring Natural Immunity After SARS-CoV-2 Infection? Rapid, Living Practice Points From the American College of Physicians (Version 1). Ann Intern Med. 2021 06; 174(6):828-835.
    View in: PubMed
    Score: 0.007
  33. Qaseem A, Yost J, Etxeandia-Ikobaltzeta I, Abraham GM, Jokela JA, Forciea MA, Miller MC, Humphrey LL, Centor RM, Andrews R, Haeme R. Should Remdesivir Be Used for the Treatment of Patients With COVID-19? Rapid, Living Practice Points From the American College of Physicians (Version 2). Ann Intern Med. 2021 05; 174(5):673-679.
    View in: PubMed
    Score: 0.007
  34. Gantzer HE, Fincher JW, Fox WE, Kane GC, Cooney TG, Abraham GM, Andrews R. Election 2020: Comparison of the American College of Physicians' Vision for a Better U.S. Health Care System With the Presidential Candidates' Plans. Ann Intern Med. 2020 12 01; 173(11):929-932.
    View in: PubMed
    Score: 0.007
  35. Qaseem A, Yost J, Etxeandia-Ikobaltzeta I, Abraham GM, Jokela JA, Forciea MA, Miller MC, Humphrey LL, Centor RM, Andrews R, Haeme R, Kansagara DL, Marcucci M. Should Remdesivir Be Used for the Treatment of Patients With COVID-19? Rapid, Living Practice Points From the American College of Physicians (Version 1). Ann Intern Med. 2021 02; 174(2):229-236.
    View in: PubMed
    Score: 0.006
  36. Qaseem A, Etxeandia-Ikobaltzeta I, Yost J, Miller MC, Abraham GM, Obley AJ, Forciea MA, Jokela JA, Humphrey LL, Centor RM, Andrews R, Bledsoe TA, Haeme R, Kansagara DL, Marcucci M. Use of N95, Surgical, and Cloth Masks to Prevent COVID-19 in Health Care and Community Settings: Living Practice Points From the American College of Physicians (Version 1). Ann Intern Med. 2020 10 20; 173(8):642-649.
    View in: PubMed
    Score: 0.006
  37. Qaseem A, Yost J, Etxeandia-Ikobaltzeta I, Miller MC, Abraham GM, Obley AJ, Forciea MA, Jokela JA, Humphrey LL. Update Alert: Should Clinicians Use Chloroquine or Hydroxychloroquine Alone or in Combination With Azithromycin for the Prophylaxis or Treatment of COVID-19? Living Practice Points From the American College of Physicians. Ann Intern Med. 2020 07 21; 173(2):W48-W51.
    View in: PubMed
    Score: 0.006
  38. Qaseem A, Yost J, Etxeandia-Ikobaltzeta I, Miller MC, Abraham GM, Obley AJ, Forciea MA, Jokela JA, Humphrey LL, Centor RM, Andrews R, Bledsoe TA, Haeme R, Kansagara DL, Marcucci M. Should Clinicians Use Chloroquine or Hydroxychloroquine Alone or in Combination With Azithromycin for the Prophylaxis or Treatment of COVID-19? Living Practice Points From the American College of Physicians (Version 1). Ann Intern Med. 2020 07 21; 173(2):137-142.
    View in: PubMed
    Score: 0.006
  39. Sathyamoorthy M, Lerman J, Amolenda PG, Wilson GA, Feldman R, Moser J, Feldman U, Abraham GE, Feldman D. Tracking tidal volume noninvasively in volunteers using a tightly controlled temperature-based device: A proof of concept paper. Clin Respir J. 2020 Mar; 14(3):260-266.
    View in: PubMed
    Score: 0.006
  40. Abara WE, Qaseem A, Schillie S, McMahon BJ, Harris AM, Abraham GM, Centor R, DeLong DM, Gantzer HE, Horwitch CA, Humphrey LL, Jokela JA, Li JMW, Lohr RH, L?pez AM, McLean RM. Hepatitis B Vaccination, Screening, and Linkage to Care: Best Practice Advice From the American College of Physicians and the Centers for Disease Control and Prevention. Ann Intern Med. 2017 12 05; 167(11):794-804.
    View in: PubMed
    Score: 0.005
  41. Al Hammadi A, Mitchell M, Abraham GM, Wang JP. Recrudescence of Plasmodium falciparum in a Primigravida After Nearly 3 Years of Latency. Am J Trop Med Hyg. 2017 03; 96(3):642-644.
    View in: PubMed
    Score: 0.005
  42. Sterling RK, Kuo A, Rustgi VK, Sulkowski MS, Stewart TG, Fenkel JM, El-Genaidi H, Mah'moud MA, Abraham GM, Stewart PW, Akushevich L, Nelson DR, Fried MW, Di Bisceglie AM. Virological outcomes and treatment algorithms utilisation in observational study of patients with chronic hepatitis C treated with boceprevir or telaprevir. Aliment Pharmacol Ther. 2015 Apr; 41(7):671-85.
    View in: PubMed
    Score: 0.004
  43. Chhabra L, Abraham GM, McGillicuddy GT. A nail in the head. Lancet. 2014 Feb 01; 383(9915):e10.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.